In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Bio-Techne pays $250mm plus earn-outs to buy Exosome Diagnostics

Executive Summary

Bio-Techne Corp. will pay $250mm to acquire privately held biofluid-based diagnostics firm Exosome Diagnostics Inc. The deal also includes up to $325mm in earn-outs based on achievement of certain EBITDA targets in 2020 and 2022.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
    • Urine-based Testing
  • Research, Analytical Equipment & Supplies
Deal Status
  • Final
Deal Type
  • Acquisition
    • Includes Earnout
    • Intra-Biotech Deal
    • Full Acquisition
    • Includes Contract
    • Acquisition of Private Biotech
    • Payment Includes Cash

Related Companies